SCHEMBL6410210

SCHEMBL6410210

OCCSc1nnc(-c2ccc(Cl)c(Cl)c2)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 1/20 0.43
EPHX2 P34913 1/20 0.36
AHR P35869 2/20 0.36
TYMP P19971 1/20 0.35
CDK1 P06493 1/20 0.35
MAPK14 Q16539 1/20 0.34
NPY5R Q15761 3/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
HTT P42858 2/20 0.33
NOTUM Q6P988 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
ALOX12 P18054 1/20 0.33
CXCR2 P25025 1/20 0.33
CYP1B1 Q16678 1/20 0.33
PRKAG1 P54619 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408541 0.83 KDM4E (0.43) HRH1MEN1KMT2AHTTNOTUM
SCHEMBL6404036 0.81 PRKAG1 (0.49) HRH1TYMPMEN1KMT2AMAPT
SCHEMBL6405546 0.80 HRH1 (0.42) HRH1AHRMEN1KMT2AHTT
SCHEMBL6404441 0.77 ALPL (0.53) EPHX2MAPK14MEN1KMT2AMAPT
SCHEMBL6409235 0.77 NPY5R (0.43) HRH1MAPK14NPY5RMEN1KMT2A
SCHEMBL6406938 0.76 SIGMAR1 (0.48) MAPK14MEN1KMT2AMAPTKDM4E
SCHEMBL18552402 0.72 DHODH (0.43) EPHX2MAPK14HTTMAPTGAA
SCHEMBL6407085 0.71 PTGS2 (0.44) HRH1MAPTKDM4E
SCHEMBL17214740 0.69 PRKAG1 (0.43) TYMPMEN1KMT2AKDM4EPRKAG1
SCHEMBL418276 0.68 HRH1 (0.49) HRH1AHRTYMPMAPK14NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT HRH1 2884/4885EPHX2 359/4885AHR 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.